Numerous clinical trials evaluate the clinical utility, pharmacokinetics, and safety of mycophenolate mofetil from Phase 1 through Phase 4 across multiple therapeutic areas. These studies examine conditions including renal transplant complications, systemic lupus erythematosus, autoimmune hepatitis, and hematological malignancies, with statuses spanning completed, actively recruiting, withdrawn, and terminated. Sponsored by academic medical centers, university hospitals, and biopharmaceutical organizations such as Bristol-Myers Squibb, these investigations highlight the agent's broad applications in organ transplantation and autoimmune regulation.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06412497 | RECRUITING | Severe Aplastic Anemia; Acquired Amegakaryocytic Thrombocytopenia; Acquired Pure Red Cell Aplasia; Paroxysmal Nocturnal Hemoglobinuria |
Masonic Cancer Center, University of Minnesota |
2024-06-05 | PHASE2 |
| NCT07524530 | NOT_YET_RECRUITING | Core Binding Factor Alpha Subunits; Hematologic Neoplasms; Leukemia; Lymphoma |
National Cancer Institute (NCI) |
2026-09-09 | PHASE2 |
| NCT04877288 | RECRUITING | Renal Allograft Recipients |
Bristol-Myers Squibb |
2021-07-21 | PHASE3 |
| NCT06013423 | RECRUITING | Acute Leukemia of Ambiguous Lineage; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm; Hematopoietic and Lymphatic System Neoplasm; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Chronic Myeloid Leukemia, BCR-ABL1 Positive |
Fred Hutchinson Cancer Center |
2024-07-23 | PHASE2 |
| NCT05027945 | RECRUITING | Immunodeficiency; Hematopoietic Stem Cell Transplantation |
National Cancer Institute (NCI) |
2023-02-23 | PHASE2 |
| NCT06568549 | RECRUITING | Kidney Transplantation; Mycophenolate Mofetil |
Mayo Clinic |
2025-06-13 | PHASE4 |
| NCT06942156 | NOT_YET_RECRUITING | Heart Transplant |
Chong Kun Dang Pharmaceutical |
2025-08-14 | PHASE4 |
| NCT07162038 | RECRUITING | Hematologic Malignancies; Hematologic Neoplasms |
National Cancer Institute (NCI) |
2025-11-14 | PHASE1 |
| NCT06872333 | RECRUITING | Graft Failure; Sickle Cell Disease; Hemoglobinopathies |
Masonic Cancer Center, University of Minnesota |
2024-11-19 | PHASE2 |
| NCT07493538 | RECRUITING | AML; MDS; Acute Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2026-04-10 | PHASE2 |
| NCT07605364 | NOT_YET_RECRUITING | Advanced Glioblastoma |
Alliance for Clinical Trials in Oncology |
2026-06-10 | PHASE2; PHASE3 |
| NCT07412470 | RECRUITING | Kidney Transplant Rejection |
Sanofi |
2026-03-13 | PHASE2; PHASE3 |
| NCT03121001 | RECRUITING | Sickle Cell Disease |
University of Illinois at Chicago |
2017-03-20 | PHASE2 |
| NCT07767188 | NOT_YET_RECRUITING | Lupus Nephritis |
Zhao Minghui |
2026-09-10 | PHASE3 |
| NCT05236036 | ACTIVE_NOT_RECRUITING | Astrocytoma; Glioblastoma; Glioblastoma, IDH-Wildtype; MGMT-Unmethylated Glioblastoma; Recurrent Glioblastoma |
Northwestern University |
2022-08-08 | PHASE1 |
| NCT07359859 | RECRUITING | Hematologic Malignancies |
Memorial Sloan Kettering Cancer Center |
2026-01-20 | PHASE2 |
| NCT07675291 | NOT_YET_RECRUITING | Lupus Nephritis |
Nanfang Hospital, Southern Medical University |
2026-06 | |
| NCT02954939 | RECRUITING | Lupus Nephritis |
The University of Hong Kong |
2017-03-01 | |
| NCT06549231 | RECRUITING | Interstitial Lung Disease With Systemic Sclerosis |
University Hospital, Tours |
2025-01-08 | PHASE3 |
| NCT05327023 | RECRUITING | Hematologic Neoplasms |
National Cancer Institute (NCI) |
2022-05-23 | PHASE1; PHASE2 |
| NCT06055608 | RECRUITING | Kidney Transplant |
National Institute of Allergy and Infectious Diseases (NIAID) |
2024-05-22 | PHASE2 |
| NCT05088356 | ACTIVE_NOT_RECRUITING | Allogeneic Hematopoietic Cell Transplantation (HCT); Advanced Hematologic Malignancies; Acute Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders |
Stanford University |
2021-09-07 | PHASE1 |
| NCT07663422 | NOT_YET_RECRUITING | Immune-mediated Hepatitis; Immune-related Adverse Event |
Fox Chase Cancer Center |
2026-06-30 | PHASE2 |
| NCT06973668 | RECRUITING | AML |
M.D. Anderson Cancer Center |
2025-07-22 | PHASE2 |
| NCT03670966 | RECRUITING | Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Acute Myeloid Leukemia in Remission; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome With Excess Blasts; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia; Recurrent Mixed Phenotype Acute Leukemia; Refractory Mixed Phenotype Acute Leukemia; Hematopoietic and Lymphoid Cell Neoplasm |
Fred Hutchinson Cancer Center |
2019-07-10 | PHASE1; PHASE2 |
| NCT01861106 | RECRUITING | GATA2; Immunodeficiency; MDS |
National Cancer Institute (NCI) |
2013-07-24 | PHASE2 |
| NCT07548983 | RECRUITING | Acute Myeloid Leukemia |
OHSU Knight Cancer Institute |
2026-04-21 | PHASE1 |
| NCT04232085 | RECRUITING | Primary Immune Deficiency Disorder; Immune Deficiency Disease; Bone Marrow Failure; Short Telomere Length; Fanconi Anemia; Non Fanconi DNA-DSB Repair Disorder; Hoyeraal-Hreidarsson Syndrome; Dyskeratosis Congenita; Telomere Biology Disorder; Short Telomere Syndrome |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2020-02-12 | PHASE2 |
| NCT06680661 | RECRUITING | Acute Myelogenous Leukemia; Acute Lymphatic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndromes; Myelodysplastic Syndrome Other; Chronic Myelomonocytic Leukemia; Lymphoma; Hodgkin Lymphoma |
Leland Metheny |
2025-02-25 | PHASE2 |
| NCT05805605 | RECRUITING | Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Biphenotypic Acute Leukemia; Undifferentiated Leukemia; Prolymphocytic Leukemia; Chronic Myelogenous Leukemia; Plasma Cell Leukemia; Myelodysplastic Syndromes; Leukemia, Myeloid; Myelodysplastic Syndrome With Excess Blasts-1; Burkitt Lymphoma; Relapsed T-Cell Lymphoma; Relapsed Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Marginal Zone Lymphoma; Follicular Lymphoma; Myeloproliferative Neoplasm; Myelofibrosis |
Masonic Cancer Center, University of Minnesota |
2023-05-01 | PHASE2 |
| NCT07796620 | NOT_YET_RECRUITING | Acute Leukemia; Myelodysplastic Syndromes; Severe Aplastic Anemia (SAA) |
Peking University People's Hospital |
2026-10-01 | PHASE1; PHASE2 |
| NCT04888741 | RECRUITING | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; Non Hodgkin Lymphoma; Hodgkin Lymphoma; Multiple Myeloma; Chronic Myelogenous Leukemia; Myelofibrosis |
University of Birmingham |
2021-02-22 | PHASE2 |
| NCT04022239 | RECRUITING | Hematopoietic and Lymphoid System Neoplasm |
M.D. Anderson Cancer Center |
2020-03-13 | PHASE1; PHASE2 |
| NCT04469842 | RECRUITING | Lung Transplant; Complications |
Vanderbilt University Medical Center |
2023-12-01 | EARLY_PHASE1 |
| NCT05436418 | RECRUITING | Peripheral Blood Stem Cell Transplantation; Hematopoietic Stem Cell Transplantation |
National Cancer Institute (NCI) |
2022-11-18 | PHASE1; PHASE2 |
| NCT06258915 | NOT_YET_RECRUITING | Non Infectious Uveitis |
Assistance Publique - Hôpitaux de Paris |
2024-03-01 | PHASE3 |
| NCT07785128 | NOT_YET_RECRUITING | IgA Nephropathy |
Shaheed Suhrawardy Medical College and Hospital |
2026-09-01 | PHASE2 |
| NCT04370301 | RECRUITING | Primary Myelofibrosis; Secondary Myelofibrosis |
Fred Hutchinson Cancer Center |
2021-02-09 | PHASE2 |
| NCT04959175 | RECRUITING | Hematologic Neoplasms |
National Cancer Institute (NCI) |
2021-09-23 | PHASE1; PHASE2 |
| NCT04375631 | RECRUITING | Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelomonocytic Leukemia; Refractory Mixed Phenotype Acute Leukemia; Refractory Myelodysplastic Syndrome; Refractory Acute Leukemia of Ambiguous Lineage; Refractory Acute Undifferentiated Leukemia |
Fred Hutchinson Cancer Center |
2020-12-03 | PHASE1 |
| NCT05736419 | RECRUITING | Sickle Cell Disease; Thalassemia, Beta; Thalassemia |
Memorial Sloan Kettering Cancer Center |
2023-02-09 | PHASE2 |
| NCT05951517 | RECRUITING | Henoch-Schönlein Purpura; Gastrointestinal Injury; Mycophenolate Mofetil |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2023-01-01 | |
| NCT06001385 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Acute Leukemia; Myelodysplastic Syndromes; Chronic Myeloid Leukemia; Chronic Lymphocytic Leukemia; Myeloproliferative Neoplasm; Lymphoma; Chronic Myelomonocytic Leukemia; Pro-Lymphocytic Leukemia; Myelofibrosis |
Center for International Blood and Marrow Transplant Research |
2023-12-08 | PHASE2 |
| NCT04644016 | RECRUITING | AML; ALL; MDS; MPD Withou Myelofibrosis; NHL or HL; Inherited Metabolic Disorders; Hemoglobinopathies; Bone Marrow Failure; HLH |
Memorial Sloan Kettering Cancer Center |
2020-11-20 | PHASE2 |
| NCT01659606 | ACTIVE_NOT_RECRUITING | Dyskeratosis Congenita; Hoyeraal Hreidarsson Syndrome; Revesz Syndrome; Aplastic Anemia |
Boston Children's Hospital |
2012-07 | PHASE2 |
| NCT05626387 | ACTIVE_NOT_RECRUITING | Hypersensitivity Pneumonitis |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2022-11-23 | PHASE4 |
| NCT04477629 | RECRUITING | Heart Transplantation |
NYU Langone Health |
2020-08-06 | PHASE2 |
| NCT04904588 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Mixed Phenotype Acute Leukemia; Acute Leukemia; Myelodysplastic Syndromes; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Lymphoma |
Center for International Blood and Marrow Transplant Research |
2021-09-30 | PHASE2 |
| NCT05843968 | UNKNOWN | Nephrotic Syndrome in Children |
Children's Hospital of Chongqing Medical University |
2023-01-29 | PHASE2 |
| NCT05622318 | ACTIVE_NOT_RECRUITING | Graft-versus-host Disease |
Medical College of Wisconsin |
2023-08-29 | PHASE2 |
| NCT05193565 | ACTIVE_NOT_RECRUITING | Kidney Transplantation |
Chong Kun Dang Pharmaceutical |
2021-11-19 | PHASE4 |
| NCT04384692 | ACTIVE_NOT_RECRUITING | Primary Myelofibrosis; Secondary Myelofibrosis |
Fred Hutchinson Cancer Center |
2020-12-18 | PHASE2 |
| NCT04547049 | ACTIVE_NOT_RECRUITING | Leukemia; MDS |
First Affiliated Hospital of Zhejiang University |
2020-09-01 | PHASE3 |
| NCT03292861 | ENROLLING_BY_INVITATION | Heart Transplantation |
Cedars-Sinai Medical Center |
2018-09-13 | PHASE2 |
| NCT06789315 | NOT_YET_RECRUITING | Alcoholic Hepatitis |
Institute of Liver and Biliary Sciences, India |
2025-01-20 | |
| NCT05807932 | RECRUITING | Myelodysplastic Syndromes; Secondary Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia |
Heinrich-Heine University, Duesseldorf |
2023-06-26 | PHASE1; PHASE2 |
| NCT06752694 | ACTIVE_NOT_RECRUITING | Aplastic Anemia |
Fred Hutchinson Cancer Center |
2025-09-25 | PHASE2 |
| NCT06650124 | NOT_YET_RECRUITING | Autoimmune Hepatitis |
Institute of Liver and Biliary Sciences, India |
2024-11-01 | PHASE2; PHASE3 |
| NCT04207177 | UNKNOWN | Kidney Transplant; Complications; Immune Suppression |
Oslo University Hospital |
2019-10-30 | PHASE4 |
| NCT06044493 | COMPLETED | Kidney Transplant |
Chong Kun Dang Pharmaceutical |
2023-11-14 | PHASE4 |
| NCT05907746 | ACTIVE_NOT_RECRUITING | GATA2; Immunodeficiency |
National Cancer Institute (NCI) |
2023-11-29 | PHASE2 |
| NCT05916781 | UNKNOWN | Systemic Lupus Erythematosus; Lupus Nephritis |
Chinese SLE Treatment And Research Group |
2023-07-01 | PHASE4 |
| NCT02416388 | RECRUITING | Acute Myeloid Leukemia (AML) |
University Hospital, Angers |
2015-01 | PHASE2; PHASE3 |
| NCT04868786 | UNKNOWN | Hematopoietic Stem Cell Transplantation |
Seoul National University Hospital |
2020-10-26 | PHASE1 |
| NCT03797196 | ACTIVE_NOT_RECRUITING | Renal Transplant Recipients; Elderly Patients; Immunosuppression |
University Medical Center Groningen |
2019-07-29 | PHASE4 |
| NCT05495893 | UNKNOWN | Mycophenolate Mofetil; Cyclophosphamide; Lupus Nephritis |
Second Xiangya Hospital of Central South University |
2022-07-25 | PHASE4 |
| NCT05115630 | COMPLETED | Myeloid Malignancies; Acute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia |
M.D. Anderson Cancer Center |
2022-04-08 | PHASE2 |
| NCT03246906 | TERMINATED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Aggressive Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Diffuse Large B-Cell Lymphoma; Mantle Cell Lymphoma; Myelodysplastic Syndrome; Myelodysplastic/Myeloproliferative Neoplasm; Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Hematologic and Lymphocytic Disorder; Blastic Plasmacytoid Dendritic Cell Neoplasm |
Fred Hutchinson Cancer Center |
2017-09-11 | PHASE2 |
| NCT03434730 | COMPLETED | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Acute Leukemia; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorder; Non Hodgkin Lymphoma; Hodgkin Lymphoma; Leukemia |
Memorial Sloan Kettering Cancer Center |
2018-02-07 | PHASE2 |
| NCT05570409 | TERMINATED | Inflammatory Cardiomyopathy |
LMU Klinikum |
2023-03-28 | PHASE2; PHASE3 |
| NCT05113004 | RECRUITING | Primary Sjögren's Syndrome (pSS) |
Assistance Publique - Hôpitaux de Paris |
2022-01-20 | PHASE2 |
| NCT02220985 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Leukemia of Ambiguous Lineage; Acute Undifferentiated Leukemia; Allogeneic Hematopoietic Stem Cell Transplant Recipient; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Blastic Plasmacytoid Dendritic Cell Neoplasm; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Donor; Lymphoblastic Lymphoma; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Excess Blasts-1; Myelodysplastic Syndrome With Excess Blasts-2; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission |
Fred Hutchinson Cancer Center |
2015-03-23 | PHASE2 |
| NCT03712878 | COMPLETED | Hematopoietic and Lymphoid Cell Neoplasm |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2018-09-19 | PHASE2 |
| NCT04477200 | ACTIVE_NOT_RECRUITING | Recurrent Glioblastoma; Recurrent Gliosarcoma; Recurrent Astrocytoma, Grade IV; Newly Diagnosed Glioblastoma; Newly Diagnosed Gliosarcoma; Newly Diagnosed Astrocytoma, Grade IV |
University of Michigan Rogel Cancer Center |
2020-08-05 | PHASE1 |
| NCT06365437 | TERMINATED | Kidney Transplantation |
ITB-Med LLC |
2021-06-06 | PHASE2 |
| NCT04838704 | COMPLETED | Graft Versus Host Disease |
Zhejiang University |
2021-04-01 | |
| NCT01428973 | UNKNOWN | Graft-Versus-Host Disease; Hematological Malignancies |
University of Liege |
2011-09 | PHASE2 |
| NCT05049863 | TERMINATED | Small-cell Lung Cancer; Small Cell Lung Carcinoma |
Washington University School of Medicine |
2023-02-27 | PHASE1 |
| NCT05256537 | ACTIVE_NOT_RECRUITING | Hematologic Neoplasms |
Ronald Paquette |
2022-04-26 | PHASE2 |
| NCT04530487 | TERMINATED | Desmoplastic Small Round Cell Tumor; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Desmoplastic Small Round Cell Tumor; Recurrent Malignant Peripheral Nerve Sheath Tumor; Recurrent Malignant Solid Neoplasm; Recurrent Neuroblastoma; Recurrent Rhabdomyosarcoma; Refractory Desmoplastic Small Round Cell Tumor; Refractory Malignant Peripheral Nerve Sheath Tumor; Refractory Malignant Solid Neoplasm; Refractory Neuroblastoma; Refractory Rhabdomyosarcoma |
M.D. Anderson Cancer Center |
2020-08-19 | PHASE2 |
| NCT03216967 | COMPLETED | BK Virus Nephropathy After Kidney Transplantation |
University Hospital, Strasbourg, France |
2018-01-15 | PHASE4 |
| NCT05666336 | UNKNOWN | Systemic Lupus Erythematosus |
Fen Li |
2022-12-31 | PHASE4 |
| NCT05306873 | TERMINATED | Systemic Lupus Erythematosus |
National Institute of Allergy and Infectious Diseases (NIAID) |
2022-11-30 | PHASE2 |
| NCT01701986 | COMPLETED | Hematopoietic Cell Transplantation Recipient; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Refractory T-Cell Non-Hodgkin Lymphoma |
M.D. Anderson Cancer Center |
2012-10-25 | PHASE1; PHASE2 |
| NCT00357565 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Childhood Acute Myeloid Leukemia in Remission; Recurrent Childhood Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Childhood Acute Lymphoblastic Leukemia in Remission; Previously Treated Myelodysplastic Syndrome; Secondary Myelodysplastic Syndrome; Refractory Anemia With Excess Blasts in Transformation; Refractory Anemia With Excess Blasts; Refractory Anemia; De Novo Myelodysplastic Syndrome; Childhood Myelodysplastic Syndrome |
Masonic Cancer Center, University of Minnesota |
2005-11 | PHASE2 |
| NCT06279494 | UNKNOWN | Acute Leukemia; Myelodysplastic Syndromes; Severe Aplastic Anemia |
Peking University People's Hospital |
2024-03 | PHASE1; PHASE2 |
| NCT01203722 | COMPLETED | Hematologic Malignancies |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-09 | PHASE1; PHASE2 |
| NCT04942730 | COMPLETED | Leukemia, Acute Lymphoblastic; Myeloid Leukemia, Acute; Biphenotypic Acute Leukemia; Lymphoblastic Lymphoma; Myelodysplastic Syndromes; Myeloproliferative Neoplasm |
St. Petersburg State Pavlov Medical University |
2021-01-21 | PHASE2 |
| NCT05702931 | Not yet recruiting | Hyperglycemia|Renal Transplant Complication Primary Non-Function|Diabetes |
Rigshospitalet Denmark|Aarhus University Hospital|Odense University Hospital |
2024-04-01 | Phase 4 |
| NCT05170828 | WITHDRAWN | Acute Leukemia; Myelodysplastic Syndromes; T-lymphoblastic Lymphoma; Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Acute Biphenotypic Leukemia; Acute Undifferentiated Leukemia |
Ossium Health, Inc. |
2022-09 | PHASE1 |
| NCT04773392 | TERMINATED | Kidney Transplantation; Kidney Transplant Rejection |
University of Southern California |
2021-11-23 | PHASE4 |
| NCT06288932 | COMPLETED | Immune Thrombocytopenia Purpura |
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan |
2023-08-18 | PHASE3 |
| NCT02566304 | COMPLETED | Acute Myeloid Leukemia; Acute Myeloid Leukemia in Remission; Aplastic Anemia; Chronic Myelomonocytic Leukemia; Hodgkin Lymphoma; Indolent Non-Hodgkin Lymphoma; Malignant Neoplasm; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Plasma Cell Myeloma; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ring Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2015-11-13 | PHASE2 |
| NCT04927390 | UNKNOWN | Systemic Sclerosis; Limited Cutaneous Systemic Sclerosis |
University College, London |
2021-12-08 | PHASE2 |
| NCT02880293 | COMPLETED | Hematologic Malignancy |
Memorial Sloan Kettering Cancer Center |
2016-08-23 | |
| NCT01850108 | UNKNOWN | Sickle Cell Disease; Hemoglobinopathies |
Vanderbilt-Ingram Cancer Center |
2013-05 | |
| NCT04311632 | COMPLETED | Kidney Transplantation |
ITB-Med LLC |
2021-05-26 | PHASE2 |
| NCT05293509 | WITHDRAWN | Stem Cell Transplantation |
M.D. Anderson Cancer Center |
2022-03-02 | PHASE2 |
| NCT01413100 | COMPLETED | Systemic Scleroderma |
Fred Hutchinson Cancer Center |
2011-09-15 | PHASE2 |
| NCT04066114 | COMPLETED | Living-Donor Kidney Transplant; Kidney Transplant Recipients |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-12-11 | PHASE1; PHASE2 |
| NCT03899103 | COMPLETED | Steroid-Dependent Nephrotic Syndrome |
Nilratan Sircar Medical College |
2019-05-15 | PHASE3 |
| NCT03192397 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia in Remission; Adult Acute Lymphoblastic Leukemia in Complete Remission; Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission; Chronic Myelomonocytic Leukemia in Remission; Graft Versus Host Disease; Hodgkin Lymphoma; Minimal Residual Disease; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Plasma Cell Myeloma; Severe Aplastic Anemia; Waldenstrom Macroglobulinemia |
Roswell Park Cancer Institute |
2017-08-09 | PHASE1; PHASE2 |
| NCT01810588 | COMPLETED | Hematologic Malignancies |
Weill Medical College of Cornell University |
2012-10-16 | PHASE2 |
| NCT02711826 | COMPLETED | Kidney Transplant; Adult Living Donor Kidney Transplant Recipients; Renal Transplant; Living Kidney Donor |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-09-20 | PHASE1; PHASE2 |
| NCT04895423 | UNKNOWN | Atopic Dermatitis |
National Medical Research Center for Children's Health, Russian Federation |
2021-11-25 | PHASE4 |
| NCT05859191 | Recruiting | Systemic Lupus Erythematosus|Physiopathology |
University Hospital Tours|Research Center for Respiratory Diseases Inserm U1100 |
2023-07-21 | -- |
| NCT02900443 | UNKNOWN | Autoimmune Hepatitis |
Radboud University Medical Center |
2017-01 | PHASE4 |
| NCT04048161 | COMPLETED | Nephrotic Syndrome in Children |
The Children's Hospital of Zhejiang University School of Medicine |
2019-11-12 | PHASE4 |
| NCT03386539 | COMPLETED | Pediatric Heart Transplantation; Immunosuppression; Chronic Kidney Diseases; Cardiac Allograft Vasculopathy; Heart Transplant Failure and Rejection; Post-transplant Lymphoproliferative Disorder; Heart Transplant Infection |
Boston Children's Hospital |
2018-01-29 | PHASE3 |
| NCT01811368 | UNKNOWN | Refractory Non Hodgkin Lymphoma; Relapsed Non Hodgkin Lymphoma |
Joseph Tuscano |
2013-03-12 | PHASE2 |
| NCT04669210 | COMPLETED | Graft-versus-host-disease; Stem Cell Transplant Complications; Acute Myeloid Leukemia; Acute Lymphoid Leukemia |
St. Petersburg State Pavlov Medical University |
2020-11-03 | PHASE2 |
| NCT04473924 | WITHDRAWN | Infection; Transplant;Failure,Kidney |
University of California, San Francisco |
2022-07 | PHASE2 |
| NCT05221411 | UNKNOWN | Autoimmune Hepatitis |
Leiden University Medical Center |
2022-01-19 | PHASE4 |
| NCT05057481 | UNKNOWN | Autoimmune Hemolytic Anemia; Systemic Lupus Erythematosus |
Assiut University |
2021-09-15 | PHASE3 |
| NCT04444843 | UNKNOWN | Kidney Transplant Recipients |
First Affiliated Hospital Xi'an Jiaotong University |
2021-01-22 | PHASE4 |
| NCT04776850 | WITHDRAWN | Beta Thalassemia Major; Sickle Beta 0 Thalassemia; Sickle Beta Plus Thalassemia; Sickle Beta Thalassemia; Sickle Cell Disease; Sickle Cell-SS Disease |
M.D. Anderson Cancer Center |
2020-12-29 | EARLY_PHASE1 |
| NCT02582775 | COMPLETED | Epidermolysis Bullosa |
Masonic Cancer Center, University of Minnesota |
2016-03 | PHASE2 |
| NCT04903054 | WITHDRAWN | Kidney Transplantation; Renal Transplant Recipients |
National Institute of Allergy and Infectious Diseases (NIAID) |
2022-01-10 | PHASE2 |
| NCT03959241 | COMPLETED | Acute Leukemia; Chronic Myelogenous Leukemia (CML); Myelodysplasia; Lymphoma |
Medical College of Wisconsin |
2019-06-25 | PHASE3 |
| NCT05303272 | UNKNOWN | Pemphigus Vulgaris |
Tongji Hospital |
2021-02-01 | PHASE4 |
| NCT04531865 | WITHDRAWN | Frequently Relapsing Nephrotic Syndrome; Steroid-Dependent Nephrotic Syndrome |
Children's Hospital of Fudan University |
2021-01-01 | PHASE3 |
| NCT02342145 | COMPLETED | Beta-Thalassemia Major; Graft-versus-host Disease (GVHD) |
Zhongming Zhang |
2015-04 | PHASE4 |
| NCT03794492 | COMPLETED | Kidney Transplant |
Chong Kun Dang Pharmaceutical |
2018-03-31 | PHASE4 |
| NCT05284942 | UNKNOWN | Rosai-Dorfman Disease; Langerhans Cell Histiocytosis |
Tongji Hospital |
2011-10-01 | PHASE4 |
| NCT01760655 | COMPLETED | Acute Myeloid Leukemia With FLT3/ITD Mutation; Acute Myeloid Leukemia With Gene Mutations; Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM; Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214; Aplastic Anemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Follicular Lymphoma; Hodgkin Lymphoma; Myelodysplastic Syndrome; Myelofibrosis; Myeloid Leukemia; Non-Hodgkin Lymphoma; Plasma Cell Myeloma; Polycythemia Vera; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2012-12-24 | PHASE2 |
| NCT03789006 | UNKNOWN | Kidney Transplant Rejection |
University of Khartoum |
2018-03-21 | PHASE4 |
| NCT05120570 | Recruiting | Acute Leukemia|Myelodysplastic Syndromes|Myeloproliferative Neoplasm|Lymphoma |
Masonic Cancer Center University of Minnesota |
2022-03-17 | Phase 1|Phase 2 |
| NCT01904136 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Acute Myeloid Leukemia With Gene Mutations; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Therapy-Related Acute Myeloid Leukemia |
M.D. Anderson Cancer Center |
2014-04-22 | PHASE1; PHASE2 |
| NCT03088709 | TERMINATED | Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome; Non-hodgkin Lymphoma; Chronic Lymphocytic Leukemia |
Loyola University |
2017-01-18 | PHASE2 |
| NCT02248597 | COMPLETED | Graft Versus Host Disease; Hematopoietic/Lymphoid Cancer |
Wake Forest University Health Sciences |
2015-02-25 | PHASE2 |
| NCT02498977 | TERMINATED | Transplantation, Liver |
King's College London |
2015-10 | PHASE4 |
| NCT03171831 | UNKNOWN | Thalassemia Major |
First Affiliated Hospital of Guangxi Medical University |
2017-04-01 | PHASE4 |
| NCT02867800 | COMPLETED | Sickle Cell Disease; Graft Versus Host Disease |
Monica Bhatia |
2016-07 | PHASE1 |
| NCT00796068 | COMPLETED | Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Myelodysplastic Syndrome (MDS) |
Fred Hutchinson Cancer Center |
2009-02-24 | PHASE2 |
| NCT02909335 | WITHDRAWN | Liver Transplantation |
Rennes University Hospital |
2016-11 | PHASE3 |
| NCT01807611 | COMPLETED | Leukemia; Lymphoma |
St. Jude Children's Research Hospital |
2013-05-16 | PHASE2 |
| NCT02918292 | COMPLETED | Severe Aplastic Anemia |
Medical College of Wisconsin |
2017-07-03 | PHASE2 |
| NCT03828682 | UNKNOWN | Kidney Transplantation; Immunosuppression |
Simon Tremblay, PharmD, PhD |
2019-06-21 | PHASE4 |
| NCT03492255 | TERMINATED | Systemic Lupus Erythematosus (SLE) |
University of Sao Paulo General Hospital |
2018-04-12 | |
| NCT02833805 | COMPLETED | Severe Aplastic Anemia; Aplastic Anemia; Bone Marrow Failure; Immunosuppression |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2016-09 | PHASE2 |
| NCT00423514 | COMPLETED | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes |
Memorial Sloan Kettering Cancer Center |
2006-11-20 | PHASE1; PHASE2 |
| NCT03580291 | UNKNOWN | Lupus Nephritis |
Lingyun Sun |
2018-08-01 | PHASE2 |
| NCT04205240 | TERMINATED | Recurrent Plasma Cell Myeloma |
Srinivas Devarakonda |
2020-12-22 | PHASE2 |
| NCT02556931 | COMPLETED | Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Chronic Myeloid Leukemia; Chronic Myeloproliferative Disorders; Multiple Myeloma; Plasma Cell Neoplasm; Plasma Cell Dyscrasia; Myelofibrosis; Polycythemia Vera; Essential Thrombocythemia; Plasma Cell Leukemia |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2015-12 | PHASE2 |
| NCT02921789 | COMPLETED | Kidney Transplantation; Primary Focal Segmental Glomerulosclerosis (FSGS) |
Astellas Pharma Global Development, Inc. |
2017-05-22 | PHASE2 |
| NCT00352976 | COMPLETED | Fanconi Anemia |
Masonic Cancer Center, University of Minnesota |
2006-05-18 | PHASE2; PHASE3 |
| NCT02423915 | COMPLETED | Leukemia; Lymphoma |
M.D. Anderson Cancer Center |
2015-07-30 | PHASE1 |
| NCT02540395 | COMPLETED | Disorder Related to Renal Transplantation; Effects of Immunosuppressant Therapy |
Prof. Dr. Petra Reinke |
2015-03 | |
| NCT04402580 | TERMINATED | Nephrotic Syndrome Steroid-Dependent |
Istituto Giannina Gaslini |
2019-07-01 | PHASE2 |
| NCT03128359 | COMPLETED | Acute Leukemia; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Graft Versus Host Disease; Hodgkin Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma; Secondary Myelodysplastic Syndrome |
City of Hope Medical Center |
2017-05-30 | PHASE2 |
| NCT02532777 | UNKNOWN | Henoch-Schoenlein Purpura Nephritis |
Nanjing Children's Hospital |
2015-08 | PHASE2 |
| NCT04258423 | TERMINATED | Kidney Failure |
Indiana University |
2019-12-19 | PHASE3 |
| NCT03674411 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Biphenotypic/Undifferentiated Leukemia; Chronic Myelogenous Leukemia; Myelodysplasia; Relapsed Large Cell Lymphoma; Mantle Cell Lymphoma; Hodgkin Lymphoma; Burkitt Lymphoma; Relapsed T-Cell Lymphoma; Lymphoplasmacytic Lymphoma |
Masonic Cancer Center, University of Minnesota |
2019-01-02 | PHASE2 |
| NCT02904772 | WITHDRAWN | LPL Deficiency |
UniQure Biopharma B.V. |
2016-10 | PHASE2 |
| NCT03112603 | COMPLETED | Graft-versus-host Disease (GVHD) |
Incyte Corporation |
2017-06-29 | PHASE3 |
| NCT02756572 | COMPLETED | Blasts 10 Percent or More of Bone Marrow Nucleated Cells; Chronic Myelomonocytic Leukemia-2; High Grade Malignant Neoplasm; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts-2; Myeloid Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia |
University of Washington |
2016-09-22 | PHASE2 |
| NCT04147390 | UNKNOWN | Keratopathy |
Shahid Beheshti University of Medical Sciences |
2019-11 | PHASE2; PHASE3 |
| NCT02793544 | COMPLETED | Myelodysplastic Syndrome (MDS); Chronic Lymphocytic Leukemia (CLL); Chemotherapy-sensitive Lymphoma; Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma; Acute Myelogenous Leukemia (AML); Acute Biphenotypic Leukemia (ABL); Acute Undifferentiated Leukemia (AUL) |
Center for International Blood and Marrow Transplant Research |
2016-12 | PHASE2 |
| NCT01685411 | TERMINATED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome |
Masonic Cancer Center, University of Minnesota |
2013-01 | |
| NCT02487069 | COMPLETED | Acute Leukemia; Chronic Myeloid Leukemia; Myelodysplastic Syndrome |
Nanfang Hospital, Southern Medical University |
2015-06 | |
| NCT03920059 | TERMINATED | Lupus Nephritis |
Chulalongkorn University |
2019-08-20 | PHASE4 |
| NCT02677181 | COMPLETED | aGVHD |
Chinese PLA General Hospital |
2016-01 | PHASE4 |
| NCT03734601 | COMPLETED | Acute Myeloid Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorder; Chronic Lymphocytic Leukemia; B-cell Lymphoma; T-cell Lymphoma; Non Hodgkin Lymphoma; Hodgkin Lymphoma; Chronic Myelomonocytic Leukemia |
Stanford University |
2018-11-05 | PHASE2 |
| NCT02181478 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Myelodysplastic Syndromes; Myelofibrosis; Relapsed Non-Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Relapsed Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Lymphoid Malignancies; Chronic Myelogenous Leukemia |
Case Comprehensive Cancer Center |
2015-07-22 | EARLY_PHASE1 |
| NCT01921218 | COMPLETED | Failing Renal Allograft |
Andrew B Adams |
2013-08 | PHASE3 |
| NCT03099122 | COMPLETED | End-stage Renal Disease |
Sanofi |
2017-08-16 | PHASE4 |
| NCT02432339 | UNKNOWN | Psychological Stress; Hypertension, Renal |
Augusta University |
2014-04-22 | PHASE1; PHASE2 |
| NCT00309842 | COMPLETED | Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Myelofibrosis; MDS; Refractory Anemia; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Non-Hodgkin's Lymphoma; Leukemia; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2005-07-28 | PHASE2 |
| NCT02990286 | COMPLETED | Lung Disease, Interstitial |
University Hospital, Tours |
2017-01-20 | PHASE3 |
| NCT01946880 | TERMINATED | Systemic Lupus Erythematosus; SLE |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-11-20 | PHASE2 |
| NCT02839941 | UNKNOWN | Kidney Transplantation |
The First Affiliated Hospital with Nanjing Medical University |
2016-08 | |
| NCT02188719 | TERMINATED | Liver Transplantation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2014-12-17 | PHASE1 |
| NCT00303719 | TERMINATED | Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2002-03-26 | PHASE2 |
| NCT02627573 | TERMINATED | Leukemia, Chronic Myeloid; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative |
St. Petersburg State Pavlov Medical University |
2015-07 | PHASE2 |
| NCT02435901 | COMPLETED | Sickle Cell Disease; Beta Thalassemia-Major |
Northwell Health |
2008-12 | PHASE1; PHASE2 |
| NCT01570348 | TERMINATED | Crohn Disease |
Fred Hutchinson Cancer Center |
2012-07-17 | PHASE2 |
| NCT01252667 | COMPLETED | Acute Myeloid Leukemia |
Fred Hutchinson Cancer Center |
2011-01-25 | PHASE2 |
| NCT02550652 | COMPLETED | Lupus Nephritis |
Hoffmann-La Roche |
2015-11-13 | PHASE2 |
| NCT02077556 | COMPLETED | Drug Interaction Potentiation |
National Taiwan University Hospital |
2014-04 | PHASE4 |
| NCT02954198 | COMPLETED | Immunosuppression |
Medical University of South Carolina |
2016-12-01 | |
| NCT02383589 | COMPLETED | Pemphigus Vulgaris |
Hoffmann-La Roche |
2015-05-26 | PHASE3 |
| NCT01251575 | COMPLETED | Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Adult Diffuse Large B-Cell Lymphoma; Adult Myelodysplastic Syndrome; Adult Non-Hodgkin Lymphoma; Aggressive Non-Hodgkin Lymphoma; Childhood Acute Lymphoblastic Leukemia; Childhood Acute Myeloid Leukemia; Childhood Diffuse Large B-Cell Lymphoma; Childhood Myelodysplastic Syndrome; Childhood Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia in Remission; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Hematopoietic and Lymphoid Cell Neoplasm; Mantle Cell Lymphoma; Plasma Cell Myeloma; Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic Leukemia; Waldenstrom Macroglobulinemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Hodgkin Lymphoma |
Fred Hutchinson Cancer Center |
2010-12-01 | PHASE2 |
| NCT03660436 | COMPLETED | Healthy Participants |
Bristol-Myers Squibb |
2018-08-14 | PHASE1 |
| NCT01527045 | COMPLETED | Aggressive Non-Hodgkin Lymphoma; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Chronic Lymphocytic Leukemia; Loss of Chromosome 17p; Myelodysplastic/Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Aggressive Adult Non-Hodgkin Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Hodgkin Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Waldenstrom Macroglobulinemia |
Fred Hutchinson Cancer Center |
2012-09-25 | PHASE2 |
| NCT02953873 | COMPLETED | Immunosuppression |
Medical University of South Carolina |
2017-05-05 | PHASE4 |
| NCT02652468 | COMPLETED | Lymphoma |
University of Wisconsin, Madison |
2016-03-10 | |
| NCT00358657 | TERMINATED | Immunodeficiency Syndrome; Severe Aplastic Anemia; Genetic Disorder |
Fred Hutchinson Cancer Center |
2006-05-24 | PHASE2 |
| NCT00723099 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Aggressive Non-Hodgkin Lymphoma; Chronic Myelogenous Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Indolent Non-Hodgkin Lymphoma; Lymphoma; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Recurrent Chronic Lymphocytic Leukemia; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Chronic Myelogenous Leukemia; Refractory Follicular Lymphoma; Refractory Hodgkin Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Small Lymphocytic Lymphoma; T-Cell Non-Hodgkin Lymphoma |
Fred Hutchinson Cancer Center |
2008-06-25 | PHASE2 |
| NCT01008462 | COMPLETED | B-Cell Prolymphocytic Leukemia; Hypodiploidy; Loss of Chromosome 17p; Plasma Cell Leukemia; Progression of Multiple Myeloma or Plasma Cell Leukemia; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Non-Hodgkin Lymphoma; Recurrent Childhood Hodgkin Lymphoma; Recurrent Childhood Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Non-Hodgkin Lymphoma; Refractory Plasma Cell Myeloma; Refractory Small Lymphocytic Lymphoma; t(14;16); t(4;14); T-Cell Prolymphocytic Leukemia; Waldenstrom Macroglobulinemia |
Fred Hutchinson Cancer Center |
2010-03-18 | PHASE2 |
| NCT02120157 | COMPLETED | Myeloablative Conditioning; HLA-mismatched Bone Marrow Transplantation; Graft Survival; Transplantation, Bone Marrow |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2015-07-02 | PHASE2 |
| NCT00104858 | COMPLETED | Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic Lymphoma; T-Cell Large Granular Lymphocyte Leukemia |
Fred Hutchinson Cancer Center |
2004-12 | PHASE2 |
| NCT01824693 | COMPLETED | Juvenile Myelomonocytic Leukemia |
Children's Oncology Group |
2013-06-24 | PHASE2 |
| NCT02809079 | UNKNOWN | Neuromyelitis Optica Spectrum Disorders; Mycophenolate Mofetil; Efficacy and Safety |
Third Affiliated Hospital, Sun Yat-Sen University |
2016-01 | PHASE4 |
| NCT02217410 | COMPLETED | Kidney Transplantation |
Novartis Pharmaceuticals |
2015-02-05 | PHASE1; PHASE2 |
| NCT01878786 | TERMINATED | Delayed Graft Function |
Matthew Cooper |
2013-06 | PHASE2; PHASE3 |
| NCT01300572 | COMPLETED | Chronic Myelomonocytic Leukemia; Previously Treated Myelodysplastic Syndrome; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Refractory Anemia With Excess Blasts; Secondary Acute Myeloid Leukemia |
Fred Hutchinson Cancer Center |
2012-01 | PHASE1 |
| NCT02208037 | COMPLETED | Acute Leukemia; Chronic Myelogenous Leukemia; Myelodysplasia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Hodgkin's Lymphoma |
National Heart, Lung, and Blood Institute (NHLBI) |
2014-08 | PHASE2 |
| NCT02864706 | COMPLETED | Heart Transplantation |
Novartis Pharmaceuticals |
2016-01-18 | PHASE4 |
| NCT01047072 | WITHDRAWN | Systemic Scleroderma |
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium |
PHASE2 | |
| NCT00397813 | COMPLETED | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndrome; Essential Thrombocythemia; Myeloproliferative Neoplasm; Paroxysmal Nocturnal Hemoglobinuria; Polycythemia Vera; Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase; Primary Myelofibrosis; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ring Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts |
Fred Hutchinson Cancer Center |
2006-01 | PHASE2 |
| NCT02653196 | TERMINATED | Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation |
Montefiore Medical Center |
2015-09 | EARLY_PHASE1 |
| NCT01707004 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia |
University of Wisconsin, Madison |
2013-05-16 | PHASE2 |
| NCT02896205 | COMPLETED | Systemic Sclerosis; Scleroderma; Interstitial Lung Disease |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2016-10 | PHASE3 |
| NCT03108274 | COMPLETED | Healthy |
Alexion Pharmaceuticals, Inc. |
2017-04-18 | PHASE1 |
| NCT02458196 | UNKNOWN | Autoimmune Disease |
Peking Union Medical College Hospital |
2015-04 | PHASE2 |
| NCT02199041 | TERMINATED | Hematological Malignancies |
St. Jude Children's Research Hospital |
2014-07-11 | PHASE2 |
| NCT01471067 | COMPLETED | Blood And Marrow Transplantation; Leukemia; Lymphoma; Transplantation Infection; Transplantation, Bone Marrow |
M.D. Anderson Cancer Center |
2012-07-13 | PHASE1 |
| NCT01982682 | COMPLETED | Hematopoietic/Lymphoid Cancer |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2013-11-04 | PHASE2 |
| NCT01580865 | COMPLETED | Lupus Nephritis |
Ramathibodi Hospital |
2012-05 | |
| NCT02083991 | COMPLETED | Diabetes Mellitus |
Vastra Gotaland Region |
2013-01 | PHASE4 |
| NCT01652014 | WITHDRAWN | Accelerated Phase Chronic Myelogenous Leukemia; Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia |
University of Medicine and Dentistry of New Jersey |
2014-01 | PHASE2 |
| NCT02949349 | COMPLETED | Lupus Nephritis |
Genovate Biotechnology Co., Ltd., |
2015-07 | PHASE2 |
| NCT02390362 | TERMINATED | Frequent Relapsing Nephrotic Syndrome; Steroid Dependent Nephrotic Syndrome |
Nationwide Children's Hospital |
2015-01 | PHASE3 |
| NCT02178683 | UNKNOWN | Graft Versus Host Disease |
Colorado Blood Cancer Institute |
2010-11 | PHASE3 |
| NCT01714817 | TERMINATED | Lupus Nephritis |
Bristol-Myers Squibb |
2013-01-22 | PHASE3 |
| NCT00686556 | COMPLETED | Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome; Multiple Myeloma |
Masonic Cancer Center, University of Minnesota |
2012-08 | PHASE1 |
| NCT01544491 | COMPLETED | Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant |
Novartis Pharmaceuticals |
2012-08-17 | PHASE3 |
| NCT00589316 | TERMINATED | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; CD45-Positive Neoplastic Cells Present; Chronic Myelomonocytic Leukemia; Previously Treated Myelodysplastic Syndrome; Refractory Anemia With Excess Blasts; Refractory Anemia With Ring Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts |
Fred Hutchinson Cancer Center |
2007-10-05 | PHASE1 |
| NCT00793572 | COMPLETED | Refractory Plasma Cell Myeloma |
Fred Hutchinson Cancer Center |
2008-10 | PHASE2 |
| NCT00498316 | COMPLETED | Myelodysplastic Syndrome; Leukemia |
M.D. Anderson Cancer Center |
2007-07-03 | PHASE1 |
| NCT01582048 | TERMINATED | Patients Receiving Mismatched Allogeneic HCT |
Prof. Dr. med. Wolfgang Bethge |
2012-04 | PHASE2 |
| NCT01790594 | TERMINATED | Simultaneous Kidney and Pancreas Transplantation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-02 | PHASE2 |
| NCT00494741 | COMPLETED | Kidney Transplant |
Mario Negri Institute for Pharmacological Research |
2007-05 | PHASE4 |
| NCT01318915 | TERMINATED | Renal Transplant Recipients |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-07-25 | EARLY_PHASE1 |
| NCT01392989 | COMPLETED | Neural Tube Defects; Anemia; Leukemia, Myeloid; Bone Marrow Transplant Failure; Myelodysplastic Syndromes (MDS); Myeloproliferative Disorders |
Everett Meyer |
2011-03 | PHASE2 |
| NCT01860183 | COMPLETED | Kidney Transplantation; Kidney Failure |
Clinical Hospital Merkur |
2013-05 | PHASE4 |
| NCT00533442 | COMPLETED | Type 1 Diabetes |
University of Miami |
2000-09 | PHASE2 |
| NCT01903798 | COMPLETED | Alcoholic Hepatitis |
Southern California Institute for Research and Education |
2014-12 | PHASE2 |
| NCT02743247 | COMPLETED | Healthy Volunteers |
Seoul National University Hospital |
2015-10 | PHASE1 |
| NCT01856257 | TERMINATED | Primary Renal Allograft Candidate; Kidney Transplantation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-07 | PHASE2 |
| NCT01843348 | COMPLETED | Kidney Transplantation; Renal Transplantation |
Novartis Pharmaceuticals |
2012-12-27 | PHASE3 |
| NCT01284725 | COMPLETED | Nephritis of Lupus |
Assistance Publique Hopitaux De Marseille |
2011-02-16 | PHASE3 |
| NCT00566696 | COMPLETED | Leukemia, Acute Lymphocytic (ALL); Leukemia, Myeloid, Acute(AML); Leukemia, Myeloid, Chronic(CML); Juvenile Myelomonocytic Leukemia (JMML); Hemoglobinuria, Paroxysmal Nocturnal (PNH); Hodgkin Lymphoma; Lymphoma, Non-Hodgkin (NHL); Myelodysplastic Syndrome (MDS) |
St. Jude Children's Research Hospital |
2007-12-14 | PHASE2 |
| NCT01680952 | COMPLETED | Kidney Transplant Patients |
Yonsei University |
2012-09 | PHASE4 |
| NCT00005803 | COMPLETED | Prolymphocytic Leukemia; Recurrent Adult Hodgkin Lymphoma; Recurrent Childhood Hodgkin Lymphoma; Recurrent Childhood Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma; T-Cell Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic Leukemia |
Fred Hutchinson Cancer Center |
1999-09 | PHASE1; PHASE2 |
| NCT01884571 | COMPLETED | Amyotrophic Lateral Sclerosis (ALS) |
Emory University |
2013-10 | PHASE2 |
| NCT01930890 | TERMINATED | Lupus Nephritis |
Biogen |
2013-11 | PHASE2 |
| NCT01766375 | UNKNOWN | Acute Myeloid Leukemia |
Guangxi Medical University |
2012-08 | PHASE3 |
| NCT01093586 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Erythroleukemia (M6a); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Adult Pure Erythroid Leukemia (M6b); B-cell Adult Acute Lymphoblastic Leukemia; B-cell Childhood Acute Lymphoblastic Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Erythroleukemia (M6); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Minimally Differentiated Myeloid Leukemia (M0); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Juvenile Myelomonocytic Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Previously Treated Myelodysplastic Syndromes; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Secondary Myelofibrosis; Splenic Marginal Zone Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia; T-cell Adult Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia; T-cell Large Granular Lymphocyte Leukemia; Waldenstrom Macroglobulinemia |
Case Comprehensive Cancer Center |
2007-09 | PHASE2 |
| NCT01399047 | COMPLETED | Juvenile Neuronal Ceroid Lipofuscinosis |
University of Rochester |
2011-07 | PHASE2 |
| NCT00245037 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition |
OHSU Knight Cancer Institute |
2005-06 | PHASE1; PHASE2 |
| NCT03200002 | COMPLETED | To Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis Patients |
Chitwan Medical College |
2014-01-01 | PHASE2 |
| NCT00970073 | COMPLETED | Liver Transplantation |
The Cleveland Clinic |
2009-08 | |
| NCT01842269 | COMPLETED | Kidney Transplantation |
Chong Kun Dang Pharmaceutical |
2013-01 | PHASE4 |
| NCT01822483 | COMPLETED | Renal Transplantation |
Irmandade Santa Casa de Misericórdia de Porto Alegre |
2013-04 | PHASE4 |
| NCT00096161 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Graft Versus Host Disease; Hodgkin Lymphoma; Myelodysplastic/Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Plasma Cell Myeloma; Waldenstrom Macroglobulinemia |
Fred Hutchinson Cancer Center |
2003-05 | PHASE2 |
| NCT00103792 | COMPLETED | Wegener's Granulomatosis; Vasculitis |
University Medical Center Groningen |
2004-12 | PHASE3 |
| NCT01446484 | UNKNOWN | End-Stage Renal Disease; Kidney Failure |
Pirogov Russian National Research Medical University |
2011-10 | PHASE1; PHASE2 |
| NCT01175785 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Excess Blasts in Transformation; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes |
Nohla Therapeutics, Inc. |
2010-08 | PHASE2 |
| NCT00119366 | TERMINATED | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Excess Blasts in Transformation; Refractory Anemia With Ringed Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
2003-05 | PHASE2 |
| NCT00036738 | COMPLETED | Adult Acute Lymphoblastic Leukemia in Remission; Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blastic Phase; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase of Disease; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Disease |
Fred Hutchinson Cancer Center |
2001-07-13 | PHASE2 |
| NCT01780844 | COMPLETED | Kidney Transplantation |
Astellas Pharma Global Development, Inc. |
2013-03-05 | PHASE2 |
| NCT00371319 | COMPLETED | Lupus Nephritis |
Tuen Mun Hospital |
2005-09 | PHASE4 |
| NCT01766518 | UNKNOWN | Evidence of Liver Transplantation |
Chong Kun Dang Pharmaceutical |
2009-11 | PHASE4 |
| NCT00185640 | COMPLETED | Blood Cancer; Leukemia |
Stanford University |
2003-03 | PHASE2 |
| NCT00387959 | COMPLETED | Leukemia; Lymphoma |
Memorial Sloan Kettering Cancer Center |
2006-07 | PHASE2 |
| NCT00089011 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Essential Thrombocythemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Polycythemia Vera; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Myelofibrosis; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage I Small Lymphocytic Lymphoma; Stage IA Mycosis Fungoides/Sezary Syndrome; Stage IB Mycosis Fungoides/Sezary Syndrome; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Lymphoblastic Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Multiple Myeloma; Stage IIA Mycosis Fungoides/Sezary Syndrome; Stage IIB Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Small Lymphocytic Lymphoma; Stage IIIA Mycosis Fungoides/Sezary Syndrome; Stage IIIB Mycosis Fungoides/Sezary Syndrome; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Stage IVA Mycosis Fungoides/Sezary Syndrome; Stage IVB Mycosis Fungoides/Sezary Syndrome; Testicular Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia; Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2004-04 | PHASE2 |
| NCT00412360 | COMPLETED | Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome; Natural Killer Cell Lymphoblastic Leukemia/Lymphoma |
Medical College of Wisconsin |
2006-12 | PHASE3 |
| NCT01321112 | UNKNOWN | Gene Expression; Immunosuppression Conversion; Liver Transplantation |
Pontificia Universidad Catolica de Chile |
2011-02 | |
| NCT00709592 | COMPLETED | Non-Hodgkin's Lymphoma; Leukemia; Multiple Myeloma; Acute Myeloid Leukemia; Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome |
Virginia Commonwealth University |
2008-07-21 | PHASE2 |
| NCT00075478 | COMPLETED | Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Aggressive Non-Hodgkin Lymphoma; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Diffuse Large B-Cell Lymphoma; Hematopoietic and Lymphoid Cell Neoplasm; Indolent Non-Hodgkin Lymphoma; Mantle Cell Lymphoma; Myelodysplastic/Myeloproliferative Neoplasm; Plasma Cell Myeloma; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Waldenstrom Macroglobulinemia |
Fred Hutchinson Cancer Center |
2003-10 | PHASE3 |
| NCT00263328 | COMPLETED | Kidney Transplantation |
Pfizer |
2005-12 | PHASE2 |
| NCT01509300 | UNKNOWN | Acute Leukemia; Myelodysplastic Syndrome; Solid Tumors |
Asan Medical Center |
2012-01 | PHASE1; PHASE2 |
| NCT00811915 | TERMINATED | Kidney Transplantation |
University Hospital, Rouen |
2009-01 | PHASE3 |
| NCT01017029 | COMPLETED | Cardiac Transplantation |
Novartis Pharmaceuticals |
2009-09 | PHASE4 |
| NCT01363752 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2011-03-08 | PHASE4 |
| NCT00548717 | TERMINATED | Graft-vs-Host Disease |
Dana-Farber Cancer Institute |
2007-10 | PHASE2 |
| NCT00789308 | COMPLETED | Diabetes Mellitus, Type I |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-07-11 | PHASE2 |
| NCT00453388 | COMPLETED | Acute Myeloid Leukemia in Remission; de Novo Myelodysplastic Syndrome; Fanconi Anemia; Previously Treated Myelodysplastic Syndrome |
Fred Hutchinson Cancer Center |
2007-02 | PHASE2 |
| NCT01566006 | UNKNOWN | Diabetic Nephropathy; Chronic Kidney Disease |
The Nazareth Hospital, Israel |
2012-04 | |
| NCT01154387 | UNKNOWN | End Stage Renal Disease; Renal Transplant |
Tolera Therapeutics, Inc |
2010-07 | PHASE1; PHASE2 |
| NCT01109498 | UNKNOWN | Familial Lipoprotein Lipase Deficiency |
Amsterdam Molecular Therapeutics |
2007-08 | PHASE2; PHASE3 |
| NCT01304836 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2011-01-22 | PHASE4 |
| NCT01350245 | COMPLETED | Acute Myeloid Leukemia; Myelodysplastic Syndromes; Biphenotypic Leukemia; Acute Lymphocytic Leukemia; Chronic Myeloid Leukemia; Chronic Lymphocytic Leukemia; Plasma Cell Neoplasms; Lymphoma; Hodgkin's Disease; Aplastic Anemia |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2010-07 | PHASE2 |
| NCT00693446 | UNKNOWN | Pancreas Transplantation; Kidney Transplantation |
Nantes University Hospital |
2004-04 | PHASE4 |
| NCT01056822 | COMPLETED | Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft |
Novartis Pharmaceuticals |
2010-05 | PHASE4 |
| NCT01187953 | COMPLETED | Renal Failure |
Veloxis Pharmaceuticals |
2010-09 | PHASE3 |
| NCT00255684 | TERMINATED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
University of Rochester |
2003-12 | |
| NCT00763490 | COMPLETED | Hematological Malignancies |
University of Michigan Rogel Cancer Center |
2008-12 | PHASE2 |
| NCT01044745 | TERMINATED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Graft Versus Host Disease; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Waldenström Macroglobulinemia |
University of Nebraska |
2009-12-10 | PHASE2 |
| NCT00934791 | TERMINATED | Polycystic Liver Disease |
Mayo Clinic |
2009-02 | |
| NCT00669890 | TERMINATED | Acute Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome |
New York Medical College |
2004-05 | PHASE1 |
| NCT01266148 | COMPLETED | Renal Function and Chronic Allograft Vasculopathy |
Novartis Pharmaceuticals |
2009-11 | PHASE4 |
| NCT00555373 | COMPLETED | Renal Transplant |
Pediatric Nephrology of Alabama |
2007-11 | |
| NCT00824135 | COMPLETED | Hematologic Malignancies |
St. Jude Children's Research Hospital |
2009-01 | PHASE1 |
| NCT00959231 | UNKNOWN | Hematopoietic/Lymphoid Cancer |
Cancer Research UK |
2009-01 | PHASE2 |
| NCT00859131 | COMPLETED | End Stage Renal Disease |
Medical University of South Carolina |
2009-03 | |
| NCT01044667 | TERMINATED | Lung Transplantation |
Vanderbilt University |
2010-01 | |
| NCT01014442 | COMPLETED | Lung Transplantation |
Hoffmann-La Roche |
2010-01 | PHASE3 |
| NCT01742624 | COMPLETED | de Novo Kidney Transplantation |
Astellas Pharma Korea, Inc. |
2012-04 | PHASE4 |
| NCT00618527 | COMPLETED | Multiple Sclerosis |
Aaron Boster |
2006-08 | EARLY_PHASE1 |
| NCT01135329 | TERMINATED | Lymphoma; Leukemia; Myelodysplastic Syndrome |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-08 | PHASE2 |
| NCT00322101 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Acute Myeloid Leukemia/Transient Myeloproliferative Disorder; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Acute Myeloid Leukemia in Remission; Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Myelodysplastic Syndrome With Isolated Del(5q); Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
2006-01 | PHASE3 |
| NCT01711489 | COMPLETED | Healthy Subjects; Pharmacokinetics of Isavuconazole; Pharmacokinetics of Plasma Mycophenolic Acid (MPA); Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG) |
Astellas Pharma Global Development, Inc. |
2012-03 | PHASE1 |
| NCT00943228 | COMPLETED | Acute Rejection of Renal Transplant |
Nova Scotia Health Authority |
2010-02 | PHASE4 |
| NCT01002742 | COMPLETED | Graft-versus-Host Disease; Immune System Disorders |
Medical College of Wisconsin |
2010-01 | PHASE3 |
| NCT00817687 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2009-01 | PHASE4 |
| NCT01288131 | TERMINATED | Anti-r-HuEpo Associated PRCA Subjects |
Chulalongkorn University |
2009-01 | PHASE3 |
| NCT01042457 | COMPLETED | Lupus Nephritis |
Chulalongkorn University |
2009-05 | PHASE3 |
| NCT00008450 | COMPLETED | Adenosine Deaminase Deficiency; Autosomal Recessive Disorder; Immune System Disorder; Purine-Nucleoside Phosphorylase Deficiency; Severe Combined Immunodeficiency; Severe Combined Immunodeficiency With Absence of T and B Cells; X-Linked Severe Combined Immunodeficiency |
Fred Hutchinson Cancer Center |
1997-08-11 | PHASE1 |
| NCT00972101 | WITHDRAWN | Stem Cell Transplantation; Leukemia; Lymphoma; Pediatric Disorders |
M.D. Anderson Cancer Center |
2009-09 | PHASE1 |
| NCT00737659 | UNKNOWN | Renal Transplant |
Rabin Medical Center |
2008-08 | PHASE4 |
| NCT00204022 | COMPLETED | Lupus Nephritis |
Frédéric A. Houssiau, MD, PhD |
2001-02 | PHASE3 |
| NCT00539838 | TERMINATED | Systemic Lupus Erythematosus |
Genentech, Inc. |
2007-12-19 | PHASE3 |
| NCT00414128 | COMPLETED | Vasculitis |
Cambridge University Hospitals NHS Foundation Trust |
2007-03 | PHASE2; PHASE3 |
| NCT00300274 | COMPLETED | Graft Rejection |
Novartis Pharmaceuticals |
2006-01 | PHASE3 |
| NCT00717314 | COMPLETED | Liver Transplantation |
Hoffmann-La Roche |
2008-05 | PHASE4 |
| NCT00307671 | COMPLETED | Vasculitis; Wegener's Granulomatosis; Microscopic Polyangiitis; Churg-Strauss Syndrome; Polyarteritis Nodosa |
Assistance Publique - Hôpitaux de Paris |
2005-07 | PHASE4 |
| NCT00246129 | COMPLETED | Kidney Transplantation; Kidney Diseases; Kidney Failure |
EMagnusson |
2005-10 | PHASE4 |
| NCT00876616 | COMPLETED | Lupus Nephritis |
Zhi-Hong Liu, M.D. |
2009-04 | |
| NCT00105001 | COMPLETED | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndrome; Refractory Chronic Lymphocytic Leukemia; Refractory Plasma Cell Myeloma; Waldenstrom Macroglobulinemia; Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA; Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Lymphoma; Childhood Myelodysplastic Syndrome; Stage II Contiguous Adult Burkitt Lymphoma; Stage II Contiguous Adult Diffuse Large Cell Lymphoma; Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma; Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma; Stage II Adult Contiguous Immunoblastic Lymphoma; Stage II Contiguous Adult Lymphoblastic Lymphoma; Stage II Grade 1 Contiguous Follicular Lymphoma; Stage II Grade 2 Contiguous Follicular Lymphoma; Stage II Grade 3 Contiguous Follicular Lymphoma; Stage II Contiguous Mantle Cell Lymphoma; Stage II Non-Contiguous Adult Burkitt Lymphoma; Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma; Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma; Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma; Stage II Adult Non-Contiguous Immunoblastic Lymphoma; Stage II Non-Contiguous Adult Lymphoblastic Lymphoma; Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Stage II Non-Contiguous Mantle Cell Lymphoma; Stage II Small Lymphocytic Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Burkitt Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Recurrent Childhood Hodgkin Lymphoma; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Secondary Myelodysplastic Syndrome; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Immunoblastic Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Childhood Burkitt Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Lymphoblastic Lymphoma; Stage II Childhood Burkitt Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Burkitt Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Burkitt Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma |
Fred Hutchinson Cancer Center |
2004-11 | PHASE2 |
| NCT00782379 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes |
Northside Hospital, Inc. |
2008-10 | PHASE2 |
| NCT00433186 | COMPLETED | Diffuse Cutaneous Systemic Sclerosis |
Boston University |
2006-03 | PHASE1 |
| NCT00049504 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hematopoietic/Lymphoid Cancer; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage II Multiple Myeloma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Childhood Hodgkin Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2002-01 | PHASE2 |
| NCT00758602 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2008-09 | PHASE4 |
| NCT00316810 | COMPLETED | Pancreas-Kidney Transplantation |
Dr. Claudia Bösmüller |
2006-04 | PHASE3 |
| NCT00543569 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2008-02 | PHASE2 |
| NCT00360685 | COMPLETED | Mucositis; Graft-versus-host Disease |
H. Lee Moffitt Cancer Center and Research Institute |
2005-09 | |
| NCT00169910 | COMPLETED | Cardiovascular Disease |
Leiden University Medical Center |
2005-12 | PHASE4 |
| NCT00311311 | TERMINATED | Atherosclerosis; Kidney Failure |
Pfizer |
2006-04 | PHASE3 |
| NCT00354419 | TERMINATED | Aplastic Anemia |
Fred Hutchinson Cancer Center |
2006-02 | PHASE1 |
| NCT00334672 | UNKNOWN | Nonneoplastic Condition |
Children's Cancer and Leukaemia Group |
2006-03 | PHASE3 |
| NCT00506948 | TERMINATED | Hematological Malignancies; Myelodysplastic Syndrome; Leukemia; Lymphoma |
M.D. Anderson Cancer Center |
2006-09 | PHASE2 |
| NCT00991510 | TERMINATED | Stable Renal Transplant Recipients |
Teva Branded Pharmaceutical Products R&D, Inc. |
2009-08 | PHASE4 |
| NCT00060424 | COMPLETED | B-Cell Prolymphocytic Leukemia; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic Leukemia |
Fred Hutchinson Cancer Center |
2003-03 | PHASE2 |
| NCT00430677 | TERMINATED | Systemic Lupus Erythematosus |
Bristol-Myers Squibb |
2007-06 | PHASE2; PHASE3 |
| NCT00891306 | COMPLETED | Familial Lipoprotein Lipase Deficiency |
Amsterdam Molecular Therapeutics |
2009-02 | PHASE2; PHASE3 |
| NCT01220297 | TERMINATED | Hematologic Diseases; Acute-graft-versus-host Disease; Leukemia; Non-Hodgkin Lymphoma (NHL); Hodgkin Lymphoma |
Stanford University |
2006-08 | PHASE2 |
| NCT00771745 | COMPLETED | Renal Transplant Rejection; Transplants and Implants |
University of Cincinnati |
2008-09 | PHASE4 |
| NCT01033864 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2009-11 | PHASE4 |
| NCT00275509 | COMPLETED | Kidney Failure, Chronic |
Johns Hopkins University |
2007-01 | PHASE3 |
| NCT00695344 | UNKNOWN | Cardiac Transplant |
Fundacion Investigacion y Desarrollo |
2006-01 | PHASE4 |
| NCT00555321 | TERMINATED | Immunosuppression in Solid Organ Transplant |
Bristol-Myers Squibb |
2008-01 | PHASE2 |
| NCT00733733 | UNKNOWN | Renal Transplant Patients; Recipients of a Kidney From a Non-Heart-Beating Donor |
Radboud University Medical Center |
2008-01 | PHASE3 |
| NCT00740467 | UNKNOWN | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition |
Institut Paoli-Calmettes |
2008-01 | PHASE2 |
| NCT00040846 | COMPLETED | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Peripheral T-cell Lymphoma; Previously Treated Myelodysplastic Syndromes; Progressive Hairy Cell Leukemia, Initial Treatment; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2001-11 | PHASE2 |
| NCT00547196 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes |
City of Hope Medical Center |
2005-08-16 | |
| NCT00121810 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2003-08 | PHASE4 |
| NCT00240994 | COMPLETED | Kidney Failure, Chronic; Kidney Transplantation; Immunosuppression |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-01 | PHASE2 |
| NCT00183248 | COMPLETED | Kidney Transplantation; Kidney Disease; Kidney Failure |
University of Miami |
2004-09 | PHASE1; PHASE2 |
| NCT00790439 | WITHDRAWN | Diabetes Mellitus, Type I |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-07 | PHASE2 |
| NCT01550445 | UNKNOWN | Disorder Related to Renal Transplantation |
Ajou University School of Medicine |
2008-05 | PHASE4 |
| NCT00054353 | COMPLETED | Refractory Multiple Myeloma |
Fred Hutchinson Cancer Center |
2002-10 | PHASE1; PHASE2 |
| NCT00223678 | COMPLETED | Kidney Transplant |
Vanderbilt University Medical Center |
2000-06 | PHASE4 |
| NCT00617604 | COMPLETED | De Novo Kidney Transplantation |
Astellas Pharma Inc |
2007-12 | PHASE2 |
| NCT01016626 | COMPLETED | Healthy |
Chong Kun Dang Pharmaceutical |
2009-07 | PHASE1 |
| NCT00119392 | COMPLETED | B-cell Chronic Lymphocytic Leukemia; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2004-06 | PHASE2 |
| NCT00795132 | COMPLETED | Acute Leukaemia; Chronic Disease; Leukemia; Myelodysplasia; Lymphoma |
University of Utah |
2004-04 | PHASE2 |
| NCT00301951 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
University of California, San Francisco |
2004-09 | PHASE1 |
| NCT00206076 | COMPLETED | Liver Disease |
Albert Einstein Healthcare Network |
2006-08 | PHASE4 |
| NCT01364987 | COMPLETED | Healthy Subjects; Drug Interactions; Pharmacokinetics of ASP015K |
Astellas Pharma Inc |
2009-05 | PHASE1 |
| NCT00551291 | COMPLETED | Myelodysplastic Syndromes |
Hoffmann-La Roche |
2007-08 | PHASE2 |
| NCT00324506 | COMPLETED | Multiple Sclerosis |
University of Texas Southwestern Medical Center |
2006-05 | PHASE2 |
| NCT00185614 | COMPLETED | Blood Cancer; Multiple Myeloma |
Wen-Kai Weng |
2000-08 | PHASE2 |
| NCT02005562 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2006-05 | PHASE3 |
| NCT00596947 | TERMINATED | Transplants and Implants |
University of Pennsylvania |
2005-10 | PHASE4 |
| NCT00481819 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2007-07 | PHASE3 |
| NCT00113269 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2005-05 | PHASE4 |
| NCT02091414 | COMPLETED | Heart Transplantation |
Hoffmann-La Roche |
2006-08 | PHASE3 |
| NCT00224874 | COMPLETED | Graft vs Host Disease; Immune System Disorders |
National Heart, Lung, and Blood Institute (NHLBI) |
2005-09 | PHASE2 |
| NCT00420537 | TERMINATED | Kidney Dysfunction; Heart Transplantation |
University of Bologna |
2006-09 | PHASE4 |
| NCT01513044 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2009-01 | PHASE1 |
| NCT00045435 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Secondary Acute Myeloid Leukemia |
Fred Hutchinson Cancer Center |
2002-04 | PHASE2 |
| NCT01513057 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2009-01 | PHASE1 |
| NCT02081183 | TERMINATED | Lupus Nephritis |
Hoffmann-La Roche |
2006-03 | PHASE3 |
| NCT00446459 | COMPLETED | Kidney Failure, Chronic; Diabetic Nephropathies; Glomerulonephritis, IGA; Hypertension, Renal |
University of Washington |
2006-04 | PHASE2 |
| NCT00594308 | TERMINATED | Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplasia; Lymphoma, Non-Hodgkin's; Mantle-Cell Lymphoma; Hodgkin's Disease; Multiple Myeloma; Myelofibrosis |
Indiana University |
2007-10 | |
| NCT00400647 | COMPLETED | Maintenance Kidney Transplant |
Novartis |
2006-07 | PHASE4 |
| NCT01292226 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2006-12 | PHASE2 |
| NCT00170053 | COMPLETED | Kidney Diseases |
Mayo Clinic |
2005-06 | PHASE1 |
| NCT00354172 | TERMINATED | Leukemia; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2006-02 | PHASE2 |
| NCT00157014 | COMPLETED | Heart Diseases; Heart Transplantation |
Astellas Pharma Inc |
2004-05-10 | PHASE3 |
| NCT00118742 | COMPLETED | Liver Transplantation |
Hoffmann-La Roche |
2005-08 | PHASE4 |
| NCT00405860 | COMPLETED | MPO-ANCA Vasculitis; Microscopic Polyangiitis |
Mayo Clinic |
2002-12 | PHASE1 |
| NCT01080417 | COMPLETED | Healthy Volunteers |
Panacea Biotec Ltd |
2008-06 | |
| NCT00195273 | COMPLETED | Graft vs Host Disease; Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2004-11 | PHASE3 |
| NCT00594932 | COMPLETED | Systemic Lupus Erythematosus; Arthritis |
Oklahoma Medical Research Foundation |
2006-11 | PHASE1; PHASE2 |
| NCT00089141 | TERMINATED | Cancer |
Martin, Paul |
2004-05 | PHASE3 |
| NCT01080443 | COMPLETED | Healthy Volunteers |
Panacea Biotec Ltd |
2008-06 | |
| NCT00309218 | COMPLETED | Kidney Diseases |
Klinik für Kinder- und Jugendmedizin |
1999-03 | PHASE3 |
| NCT00400400 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2006-10 | PHASE4 |
| NCT00100178 | COMPLETED | Diabetes Mellitus, Type 1 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2004-05 | PHASE2 |
| NCT00318474 | TERMINATED | IgA Nephropathy |
St. Joseph's Hospital and Medical Center, Phoenix |
2002-01 | PHASE3 |
| NCT00608517 | TERMINATED | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Vanderbilt-Ingram Cancer Center |
2005-09 | |
| NCT00239005 | COMPLETED | Renal Transplant |
Novartis Pharmaceuticals |
2005-09 | PHASE4 |
| NCT00321113 | COMPLETED | KIDNEY TRANSPLANTATION |
Astellas Pharma Inc |
2004-09 | PHASE3 |
| NCT00611351 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis |
University of Nebraska |
2005-06-07 | PHASE2 |
| NCT00281879 | TERMINATED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unusual Cancers of Childhood |
OHSU Knight Cancer Institute |
2006-02 | PHASE2 |
| NCT00337493 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2005-12 | PHASE4 |
| NCT00374231 | COMPLETED | Liver Transplantation |
University of Cincinnati |
2002-10 | PHASE4 |
| NCT02554955 | COMPLETED | Heart Transplantation |
Hoffmann-La Roche |
2004-02 | PHASE4 |
| NCT00275522 | COMPLETED | Kidney Transplant |
Mayo Clinic |
2005-12 | PHASE4 |
| NCT00374647 | COMPLETED | Primary Renal Allograft |
University of Cincinnati |
2005-03 | PHASE4 |
| NCT01283841 | COMPLETED | Fasting |
Dr. Reddy's Laboratories Limited |
2007-11 | PHASE1 |
| NCT01283867 | COMPLETED | FED |
Dr. Reddy's Laboratories Limited |
2007-11 | PHASE1 |
| NCT00275535 | COMPLETED | Kidney Diseases |
Mayo Clinic |
2001-04 | PHASE4 |
| NCT00997958 | COMPLETED | Pancreatic Cancer |
Columbia University |
2004-06 | PHASE1 |
| NCT00087581 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2004-06 | PHASE4 |
| NCT00214266 | COMPLETED | Renal Transplantation |
University of Wisconsin, Madison |
2005-01 | PHASE2 |
| NCT00350181 | COMPLETED | Leukemia; Lymphoma, Non-Hodgkin; Hematologic Diseases; Acute GVHD |
Stanford University |
2006-08 | PHASE2 |
| NCT00004485 | COMPLETED | Sickle Cell Anemia |
Fred Hutchinson Cancer Center |
1999-12 | PHASE1; PHASE2 |
| NCT00295594 | COMPLETED | Liver Transplantation |
Astellas Pharma Inc |
2005-03 | PHASE3 |
| NCT00290628 | TERMINATED | Chronic Myeloproliferative Disorders; Diamond-blackfan Anemia; Fanconi Anemia; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Masonic Cancer Center, University of Minnesota |
1999-10 | |
| NCT00105235 | COMPLETED | Liver Disease; Liver Transplantation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-06 | PHASE2 |
| NCT00133172 | TERMINATED | Kidney Transplantation |
Astellas Pharma Inc |
2005-07 | PHASE4 |
| NCT00085449 | WITHDRAWN | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Alliance for Clinical Trials in Oncology |
2006-05 | PHASE1; PHASE2 |
| NCT00187941 | COMPLETED | Transplantation, Renal; Immunosuppression |
University of Florida |
2005-08 | EARLY_PHASE1 |
| NCT00053196 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myeloproliferative Neoplasms |
Alliance for Clinical Trials in Oncology |
2002-12 | PHASE2 |
| NCT00911274 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2006-10 | PHASE1 |
| NCT00170859 | COMPLETED | Heart Transplantation |
Novartis Pharmaceuticals |
2004-08 | PHASE4 |
| NCT00213590 | COMPLETED | Kidney Transplantation; Primary Prevention; Kidney Failure |
University Hospital, Rouen |
2000-04 | PHASE3 |
| NCT00910663 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2006-10 | PHASE1 |
| NCT00141037 | COMPLETED | Kidney Diseases; Kidney Transplantation; Kidney Transplant; Renal Transplantation; Renal Transplant |
National Institute of Allergy and Infectious Diseases (NIAID) |
2004-03 | PHASE1; PHASE2 |
| NCT00149942 | COMPLETED | Kidney Transplantation; Liver Transplantation |
Novartis |
2004-10 | PHASE4 |
| NCT00296309 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2004-10 | PHASE3 |
| NCT00106639 | COMPLETED | Kidney Transplantation |
Pfizer |
2005-05 | PHASE2 |
| NCT00296361 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2004-10 | PHASE3 |
| NCT00149903 | COMPLETED | Renal Transplant |
Novartis Pharmaceuticals |
2005-01 | PHASE3 |
| NCT00239863 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2004-05 | PHASE3 |
| NCT00239811 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2004-04 | PHASE3 |
| NCT00228020 | COMPLETED | Pediatric Kidney Transplantation |
Novartis |
2001-05 | PHASE3 |
| NCT00365287 | COMPLETED | Breast Cancer; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2000-06 | PHASE1; PHASE2 |
| NCT00089947 | COMPLETED | Renal Transplantation; Graft Rejection |
Genzyme, a Sanofi Company |
2003-06 | PHASE2 |
| NCT00893542 | COMPLETED | Prophylaxis of Organ Rejection |
Roxane Laboratories |
2005-11 | |
| NCT00656266 | TERMINATED | End-stage Liver Disease; Renal Insufficiency; Renal Failure |
Baylor College of Medicine |
2004-11 | PHASE4 |
| NCT00893919 | COMPLETED | Prophylaxis of Organ Rejection |
Roxane Laboratories |
2005-11 | |
| NCT00006251 | COMPLETED | Acute Undifferentiated Leukemia; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Grade III Lymphomatoid Granulomatosis; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Juvenile Myelomonocytic Leukemia; Mast Cell Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Myeloid/NK-cell Acute Leukemia; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Systemic Amyloidosis; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Renal Cell Cancer; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2000-05 | PHASE1; PHASE2 |
| NCT00238901 | COMPLETED | Liver Transplant |
Novartis |
2002-12 | PHASE3 |
| NCT00812123 | COMPLETED | Kidney Transplantation; Chronic Kidney Disease |
University Hospital, Basel, Switzerland |
2001-01 | PHASE4 |
| NCT00053014 | TERMINATED | Leukemia |
SWOG Cancer Research Network |
2003-04 | PHASE2 |
| NCT00005941 | COMPLETED | Cervical Cancer; Vaginal Cancer |
Fred Hutchinson Cancer Center |
1999-11 | PHASE2 |
| NCT00301600 | COMPLETED | IGA Nephropathy |
Nanjing University School of Medicine |
2003-01 | |
| NCT00238966 | COMPLETED | Renal Transplantation |
Novartis |
2002-11 | PHASE4 |
| NCT00064701 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2003-06 | PHASE3 |
| NCT00166244 | COMPLETED | De Novo Renal Transplant Recipient. |
Erasmus Medical Center |
2003-05 | PHASE4 |
| NCT00238979 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2003-01 | PHASE4 |
| NCT02630563 | TERMINATED | Pediatric Liver Transplantation |
Hoffmann-La Roche |
2003-05 | PHASE2 |
| NCT00363116 | COMPLETED | Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients |
University of Cincinnati |
1999-04 | PHASE4 |
| NCT00285233 | COMPLETED | Type 1 Diabetes; Hypoglycemia |
University of Minnesota |
2000-09 | PHASE1; PHASE2 |
| NCT00693381 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2003-02 | PHASE3 |
| NCT00023231 | COMPLETED | End-Stage Renal Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
2001-02 | |
| NCT00005851 | COMPLETED | Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer |
Fred Hutchinson Cancer Center |
2000-02 | PHASE1; PHASE2 |
| NCT00863252 | COMPLETED | IGA Nephropathy |
The University of Hong Kong |
2002-03 | PHASE4 |
| NCT00301652 | COMPLETED | Vasculitis; Anti-Neutrophil Cytoplasmic Antibody |
Nanjing University School of Medicine |
2003-06 | |
| NCT00001964 | COMPLETED | Severe Aplastic Anemia |
National Heart, Lung, and Blood Institute (NHLBI) |
2000-03-17 | PHASE2 |
| NCT00041288 | TERMINATED | Leukemia; Lymphoma |
University of Texas Southwestern Medical Center |
2001-10 | PHASE2 |
| NCT00003954 | COMPLETED | Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma |
Fred Hutchinson Cancer Center |
1999-03 | PHASE1; PHASE2 |
| NCT00048165 | COMPLETED | Heart Transplantation |
Hoffmann-La Roche |
1999-08 | PHASE4 |
| NCT00003572 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1998-08 | PHASE2 |
| NCT00006350 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
University of Maryland, Baltimore |
2000-01 | PHASE2 |
| NCT00110058 | COMPLETED | Leukemia |
Fred Hutchinson Cancer Center |
2005-02 | PHASE2 |
| NCT00006233 | COMPLETED | Melanoma (Skin) |
Fred Hutchinson Cancer Center |
2000-01 | PHASE2 |
| NCT00199667 | UNKNOWN | Kidney Transplant Recipients |
University Hospital, Limoges |
2002-10 | PHASE4 |
| NCT00195988 | COMPLETED | Liver Transplantation |
Children's Memorial Health Institute, Poland |
2002-09 | PHASE4 |
| NCT00198224 | COMPLETED | Renal Failure |
Indiana University |
2003-01 | |
| NCT00285350 | COMPLETED | Myasthenia Gravis |
FDA Office of Orphan Products Development |
2002-09 | PHASE3 |
| NCT00295997 | UNKNOWN | Chronic Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
University of California, San Francisco |
2005-05 | |
| NCT00849238 | WITHDRAWN | Primary Liver Transplant |
University of Wisconsin, Madison |
||
| NCT00307645 | TERMINATED | ANCA Associated Systemic Vasculitis Including Wegener's; Granulomatosis and Microscopic Polyangiitis and; Renal Limited Vasculitis |
Assistance Publique - Hôpitaux de Paris |
2003-05 | PHASE3 |
| NCT00140543 | COMPLETED | Diabetes Mellitus, Type 1; Diabetic Nephropathy |
EUROSPK Study Group |
2002-02 | PHASE3 |
| NCT00261820 | COMPLETED | Graft Rejection; Kidney Failure; Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
PHASE4 | |
| NCT00223015 | COMPLETED | Renal Transplantation |
University Hospital Schleswig-Holstein |
2004-05 | PHASE4 |
| NCT00304720 | UNKNOWN | Multiple Myeloma; Lymphoma; Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome |
Colorado Blood Cancer Institute |
2004-03 | PHASE2 |
| NCT00411515 | COMPLETED | Corneal Transplantation |
University Hospital Freiburg |
PHASE4 | |
| NCT00309270 | COMPLETED | Kidney Transplant |
Mario Negri Institute for Pharmacological Research |
2003-02 | PHASE2 |
| NCT00404794 | COMPLETED | Lupus Nephritis; Glomerulonephritis, Membranous |
Hospital Authority, Hong Kong |
2005-11 | PHASE3 |
| NCT00005935 | COMPLETED | Aplastic Anemia |
National Heart, Lung, and Blood Institute (NHLBI) |
2000-06 | PHASE2 |
| NCT00004567 | COMPLETED | Vasculitis; Wegener's Granulomatosis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2000-02 | PHASE2 |
| NCT00420472 | TERMINATED | Kidney Transplantation |
Hoffmann-La Roche |
2007-03 | PHASE4 |
| NCT00295425 | UNKNOWN | Psoriasis |
University Hospital Muenster |
2000-05 | PHASE2 |
| NCT00193635 | COMPLETED | Congenital Urological Abnormalities |
Northwell Health |
2002-03 | PHASE1 |
| NCT00027547 | COMPLETED | Leukemia |
Fred Hutchinson Cancer Center |
2001-07 | PHASE1; PHASE2 |
| NCT00166829 | UNKNOWN | Kidney Transplantation |
National Taiwan University Hospital |
2004-05 | PHASE4 |
| NCT00188955 | COMPLETED | Kidney Transplantation |
University of Manitoba |
2004-03 | PHASE4 |
| NCT00247494 | UNKNOWN | HIV Infection; Atherosclerosis |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2005-04 | PHASE4 |
| NCT00007059 | COMPLETED | Graft Versus Host Disease |
National Center for Research Resources (NCRR) |
1998-06 | |
| NCT00431119 | COMPLETED | Bullous Pemphigoid |
University Hospital Muenster |
1997-10 | PHASE2 |
| NCT00001764 | COMPLETED | Vasculitis; Wegener's Granulomatosis |
National Institute of Allergy and Infectious Diseases (NIAID) |
1998-04 | PHASE1 |
| NCT00008307 | UNKNOWN | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Herbert Irving Comprehensive Cancer Center |
1998-04 | PHASE2 |
| NCT00135967 | COMPLETED | Glomerulonephritis, Membranous |
Radboud University Medical Center |
2002-05 | PHASE2; PHASE3 |
| NCT00204230 | TERMINATED | Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation |
University Hospital Muenster |
1999-10 | |
| NCT00729768 | WITHDRAWN | Kidney Transplantation |
Genentech, Inc. |
PHASE2; PHASE3 | |
| NCT00021489 | WITHDRAWN | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 |
(data from https://clinicaltrials.gov, updated on 2026-06-03)
Check the
Mycophenolate mofetil
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Mycophenolate mofetil Solubility in DMSO
- Mycophenolate mofetil Stock Solution
- Mycophenolate mofetil Storage
- Mycophenolate mofetil Stability
- Mycophenolate mofetil Molecular Weight
- Mycophenolate mofetil SMILES
- Mycophenolate mofetil CAS Number
- Mycophenolate mofetil Chemical Structure (2D and 3D)
- Mycophenolate mofetil SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.